儿童1型糖尿病起病时糖尿病酮症酸中毒相关因素的系统综述
该系统综述纳入195篇文章,评估儿童1型糖尿病起病时糖尿病酮症酸中毒(DKA)的相关因素。发现起病年龄小于2岁、少数族裔、延迟诊断或误诊及新冠疫情期间就诊与DKA风险增加相关;而参与筛查项目或家族史与风险降低相关。
要点
- 起病年龄<2岁、少数族裔、延迟诊断或误诊及新冠疫情期间就诊与DKA风险增加相关。
- 参与筛查项目或家族史与DKA风险降低相关。
- 未来应针对上述因素制定策略以降低新发1型糖尿病患儿DKA风险。
核心结论
- 儿童1型糖尿病起病时,年龄小于2岁、少数族裔、延迟诊断或误诊及新冠疫情期间就诊与DKA风险增加相关;参与筛查项目或家族史与风险降低相关。
研究设计与样本
- 系统综述检索PubMed、Embase、Scopus、CINAHL、Web of Science及参考文献列表,纳入2011年1月至2021年11月发表的关于18岁以下人群1型糖尿病起病时DKA的原始研究,并与2011年系统综述合并,共纳入195篇文章。
主要发现
- 起病年龄<2岁 vs ≥2岁与DKA风险增加相关(OR 3.51;95% CI 2.85-4.32;P < .001)。
- 少数族裔与DKA风险增加相关(OR 0.40;95% CI 0.21-0.74;P = .004),家族史与风险降低相关(OR 0.46;95% CI 0.37-0.57;P < .001)。
- 延迟诊断与DKA风险增加相关(OR 2.27;95% CI 1.72-3.01;P < .001)。
- 参与筛查项目与DKA风险降低相关(OR 0.35;95% CI 0.21-0.59;P < .001)。
- 新冠疫情期间就诊与DKA风险增加相关(OR 2.32;95% CI 1.76-3.06;P < .001)。
临床怎么用
- 对年龄小于2岁、少数族裔、有延迟诊断或误诊风险及新冠疫情期间就诊的儿童1型糖尿病患儿应警惕DKA。
- 关注家族史和参与筛查项目等保护性因素,可能有助于降低DKA风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Presenting with diabetic ketoacidosis (DKA) at onset of type 1 diabetes (T1D) remains a risk. Following a 2011 systematic review, considerable additional articles have been published, and the review required updating. OBJECTIVE: To evaluate factors associated with DKA at the onset of T1D among pediatric patients. EVIDENCE REVIEW: In this systematic review, PubMed, Embase, Scopus, CINAHL, Web of Science, and article reference lists were searched using the population, intervention, comparison, outcome search strategy for primary research studies on DKA and T1D onset among individuals younger than 18 years that were published from January 2011 to November 2021. These studies were combined with a 2011 systematic review on the same topic. Data were pooled using a random-effects model. FINDINGS: A total of 2565 articles were identified; 149 were included, along with 46 from the previous review (total 195 articles). Thirty-eight factors were identified and examined for their association with DKA at T1D onset. Factors associated with increased risk of DKA were younger age at T1D onset (<2 years vs ≥2 years; odds ratio [OR], 3.51; 95% CI, 2.85-4.32; P < .001), belonging to an ethnic minority population (OR, 0.40; 95% CI, 0.21-0.74; P = .004), and family history of T1D (OR, 0.46; 95% CI, 0.37-0.57; P < .001), consistent with the 2011 systematic review. Some factors that were not associated with DKA in the 2011 systematic review were associated with DKA in the present review (eg, delayed diagnosis: OR, 2.27; 95% CI, 1.72-3.01; P < .001). Additional factors associated with risk of DKA among patients with new-onset T1D included participation in screening programs (OR, 0.35; 95% CI, 0.21-0.59; P < .001) and presentation during the COVID-19 pandemic (OR, 2.32; 95% CI, 1.76-3.06; P < .001). CONCLUSIONS AND RELEVANCE: In this study, age younger than 2 years at T1D onset, belonging to an ethnic minority population, delayed diagnosis or misdiagnosis, and presenting during the COVID-19 pandemic were associated with increased risk of DKA. Factors associated with decreased risk of DKA included greater knowledge of key signs or symptoms of DKA, such as a family history of T1D or participation in screening programs. Future work should focus on identifying and implementing strategies related to these factors to reduce risk of DKA among new patients with T1D.
引用
- Rugg-Gunn CEM, Dixon E, Jorgensen AL, et al. Factors Associated With Diabetic Ketoacidosis at Onset of Type 1 Diabetes Among Pediatric Patients: A Systematic Review. JAMA Pediatr. 2022. PMID: 36215053. doi:10.1001/jamapediatrics.2022.3586
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。